Search

Additional file 1: Supplemental Figure 1. Data sources of the study. Supplemental Figure 2. Annual prevalence of buprenorphine utilisation according to gender among Nordic adults aged ≥65. Supplemental Table 1. Opioids on the Nordic market during 2009–2018. Supplemental Table 2. Values in Fig. 1: Annual prevalence (%) of opioid utilisation among Nordic residents aged ≥65. Supplemental Table 3. Values in Fig. 2: Opioid utilisation in Defined Daily Doses (DDD)s/1000 inhabitant/day. Supplemental Table 4. Values in Fig. 3: Opioid utilisation in morphine milligram equivalents (MME)s/user/day. Supplemental Table 5. Values in Fig. 4: Annual prevalence (%) of the most frequent opioids among Nordic residents aged ≥65. Supplemental Table 6. Values in Fig. 5: Annual prevalence (%) of opioid utilisation according to gender. Supplemental Table 7. Values in Fig. 6: Annual prevalence (%) of opioid utilisation according to age group. Supplemental Table 8. Values in Supplemental Figure 2: Annual prevalence (%) of buprenorphine according to gender.